Reading Time: 3 minutesThe $1.8 trillion digital health market is set for massive disruption, with 73% of its value driven by M&A between healthcare enterprises and AI-native startups. Despite holding $560 billion in untapped real-world data assets, traditional healthcare companies struggle with data monetization. Strategic acquisitions—such as IQVIA’s $7 billion spree—show that leveraging RWD can unlock 10-20x investment returns. This article explores how structured M&A strategies can transform data graveyards into commercial goldmines, enhancing RWE insights, regulatory approval speed, and revenue growth. Learn how data-first acquisition models outperform traditional M&A, and why AI-powered due diligence is key to unlocking billion-dollar opportunities.
Browsing CategoryTechnology Due Diligence & IntegrationGet expert insights on evaluating and integrating technology solutions in the health tech industry. Learn how to assess digital health innovations, ensure regulatory compliance, and drive seamless technology adoption.
Get expert insights on evaluating and integrating technology solutions in the health tech industry. Learn how to assess digital health innovations, ensure regulatory compliance, and drive seamless technology adoption.